Vimarsana
Biggest News Aggregation in the World

Page 2 - Mochida News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mochida. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mochida Today - Breaking & Trending Today

Daridorexant for Insomnia Nears Approval in Japan - Vimarsana News

Daridorexant for Insomnia Nears Approval in Japan

A new drug application has been submitted in Japan for the approval of daridorexant, a dual orexin receptor antagonist for insomnia.

Test clarifies form and function in organelles - Vimarsana News

Test clarifies form and function in organelles

Researchers have developed a bacteria-based tool to test whether form follows function among organelles.

Does form follow function? Johns Hopkins Medi - Vimarsana News

Does form follow function? Johns Hopkins Medi

Scientists have long understood that parts of cells, called organelles, evolved to have certain shapes and sizes because their forms are closely related to how they function. Now, Johns Hopkins researchers have developed a bacteria-based tool to test whether, as the axiom goes, form follows function.

Idorsia sells its Asia Pacific (ex-China) operations – including select license rights to products – to Sosei Heptares for a total consideration of CHF 400 million - Vimarsana News

Idorsia sells its Asia Pacific (ex-China) operations – including select license rights to products – to Sosei Heptares for a total consideration of CHF 400 million

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 20, 2023 Idorsia Ltd today announced the sale of its operating businesses in the Asia Pacific region , including...

GNW-Adhoc: Idorsia sells its Asia Pacific (ex-China) operations - including select license rights to products - to Sosei Heptares for a total consideration of CHF 400 million - Vimarsana News

GNW-Adhoc: Idorsia sells its Asia Pacific (ex-China) operations - including select license rights to products - to Sosei Heptares for a total consideration of CHF 400 million

^Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - July 20, 2023 Idorsia Ltd (SIX: IDIA) today announced the sale of its operating businesses in the Asia Pacific (ex-China) region ("Territory"), including assignment of PIVLAZ (clazosentan) and license rights to daridorexant in ...